Compare IMAX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMAX | ATRC |
|---|---|---|
| Founded | 1967 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 1994 | 2005 |
| Metric | IMAX | ATRC |
|---|---|---|
| Price | $37.05 | $35.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $36.44 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.3M | 551.8K |
| Earning Date | 10-23-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.41 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | $377,677,000.00 | ★ $518,304,999.00 |
| Revenue This Year | $17.45 | $16.90 |
| Revenue Next Year | $6.19 | $12.29 |
| P/E Ratio | $52.14 | ★ N/A |
| Revenue Growth | 9.30 | ★ 15.80 |
| 52 Week Low | $20.48 | $28.29 |
| 52 Week High | $37.57 | $43.11 |
| Indicator | IMAX | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 69.08 | 54.23 |
| Support Level | $35.10 | $35.51 |
| Resistance Level | $37.21 | $38.90 |
| Average True Range (ATR) | 1.16 | 1.73 |
| MACD | 0.09 | 0.50 |
| Stochastic Oscillator | 84.20 | 60.73 |
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.